Literature DB >> 2609344

Investigation into the mechanism of tetracycline-induced steatosis: study in isolated hepatocytes.

D Deboyser1, F Goethals, G Krack, M Roberfroid.   

Abstract

Tetracycline is known to cause hepatic dysfunction in humans by inducing steatosis. Accumulation of fat in the liver could result from biochemical effects at various levels in the sequence from protein and triglyceride synthesis to lipoprotein secretion. The effects of tetracycline on the synthesis and secretion of triglycerides and proteins were studied in isolated rat hepatocytes surviving in suspension for up to 2.5 hr. Interpretation of the results obtained for tetracycline was made by comparison with results obtained, under the same experimental conditions, for the well-known steatogenic compounds, cycloheximide and colchicine. The data indicate that tetracycline produces a concentration-dependent inhibition of 14C-triglyceride secretion without affecting triglyceride synthesis. This inhibition explains the intracellular triglyceride accumulation. However, tetracycline does not affect protein secretion. Furthermore, it was demonstrated that the effect of tetracycline on protein synthesis was not related to inhibition of triglyceride release. In conclusion, it is proposed that the effect of tetracycline could be at the level of the association between triglycerides and apoproteins to form lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2609344     DOI: 10.1016/0041-008x(89)90252-4

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  6 in total

Review 1.  Liver cell models in in vitro toxicology.

Authors:  A Guillouzo
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

2.  Biochemical changes in isolated hepatocytes exposed to tert-butyl hydroperoxide. Implications for its cytotoxicity.

Authors:  P Buc-Calderon; I Latour; M Roberfroid
Journal:  Cell Biol Toxicol       Date:  1991-04       Impact factor: 6.691

3.  Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats.

Authors:  M Fiordaliso; N Kok; J P Desager; F Goethals; D Deboyser; M Roberfroid; N Delzenne
Journal:  Lipids       Date:  1995-02       Impact factor: 1.880

4.  Effect of a homeopathic drug, Chelidonium, in amelioration of p-DAB induced hepatocarcinogenesis in mice.

Authors:  Surjyo Jyoti Biswas; Anisur Rahman Khuda-Bukhsh
Journal:  BMC Complement Altern Med       Date:  2002-04-10       Impact factor: 3.659

5.  Early detection of metabolic changes in drug-induced steatosis using metabolomics approaches.

Authors:  Helena Y Yong; Gerald Larrouy-Maumus; Mire Zloh; Rosemary Smyth; Rayan Ataya; Christopher M Benton; Michael R Munday
Journal:  RSC Adv       Date:  2020-11-11       Impact factor: 4.036

6.  Effects of Medicinal herb Extracts and their Components on Steatogenic Hepatotoxicity in Sk-hep1 Cells.

Authors:  You-Jin Choi; Yujin Yoon; Ho-Sung Choi; Sora Park; Sehee Oh; Se-Mi Jeong; Hyo-Ryung Suh; Byung-Hoon Lee
Journal:  Toxicol Res       Date:  2011-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.